MedTrace Logo

Bisphenol A Exposure, Ovarian Function and Assisted Reproductive Technology Outcome.

NCT02377219 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 350

Last updated 2019-07-15

No results posted yet for this study

Summary

Our goal is to prospect the relationships between Bisphenol A (BPA) exposure (measured as its free and conjugated forms in blood and urine) and embryo implantation rate (measured as the ratio between the number of gestational sacs and the number of transferred embryos) after assisted reproductive technology. In order to reduce the confusion factors, the population study is limited to young women (aged 28 to 34), with regular menstrual cycles and without any medical event that could affect the implantation process

Conditions

  • Female Reproductive Problem
  • Male Reproductive Problems

Interventions

OTHER

hormonal and blood analysis

Sponsors & Collaborators

  • University Hospital, Toulouse

    lead OTHER

Principal Investigators

  • Roger LEANDRI, MD · University Hospital, Toulouse

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
28 Years
Max Age
34 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2019-07-31
Completion
2019-07-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02377219 on ClinicalTrials.gov